Healthcare Industry News:  lopinavir/ritonavir 

Biopharmaceuticals HIV/AIDS FDA

 News Release - December 21, 2007

Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration



Source: Tibotec

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.